NCT05615129View on ClinicalTrials.gov

Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

October 30, 2022

Conditions
Esophagus Cancer
Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
collaborator

First Affiliated Hospital of Shantou University Medical College

OTHER

collaborator

Peking University Shenzhen Hospital

OTHER

lead

Guangdong Provincial People's Hospital

OTHER

NCT05615129 - Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting | Biotech Hunter | Biotech Hunter